MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Search

Penumbra Inc

Închisă

SectorSănătate

350.36 12.31

Rezumat

Modificarea prețului

24h

Curent

Minim

312.23

Maxim

352

Indicatori cheie

By Trading Economics

Venit

581K

46M

Vânzări

15M

355M

P/E

Medie Sector

76.246

90.831

Marjă de profit

12.927

Angajați

4,500

EBITDA

4M

55M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+13% upside

Dividende

By Dow Jones

Următoarele câștiguri

17 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

3.7B

13B

Deschiderea anterioară

338.05

Închiderea anterioară

350.36

Sentimentul știrilor

By Acuity

21%

79%

31 / 361 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Penumbra Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 ian. 2026, 13:29 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 ian. 2026, 12:35 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 ian. 2026, 12:29 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

15 ian. 2026, 14:37 UTC

Acțiuni populare

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 ian. 2026, 13:45 UTC

Achiziții, Fuziuni, Preluări

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 ian. 2026, 12:04 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 ian. 2026, 12:03 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 ian. 2026, 12:01 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 ian. 2026, 12:00 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 ian. 2026, 12:00 UTC

Achiziții, Fuziuni, Preluări

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Comparație

Modificare preț

Penumbra Inc Așteptări

Obiectiv de preț

By TipRanks

13% sus

Prognoză pe 12 luni

Medie 354.17 USD  13%

Maxim 388 USD

Minim 266 USD

În baza a 15 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPenumbra Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

15 ratings

9

Cumpărare

6

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

288.28 / 292.9394Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

31 / 361 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat